[
  {
    "sentence": "Z-score normalized maps were binarized (only positive voxels) to create an overlap mask that combine both arterial and venous mixed (AVOL map) regions (Fig. 1), similar to those described by LaViolette et al. [17].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Z-score normalized maps were binarized (only positive voxels) to create an overlap mask that combine both arterial and venous mixed (AVOL map) regions (Fig. 1), similar to those described by LaViolette et al. [17].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Z-score normalized maps were binarized (only positive voxels) to create an overlap mask that combine both arterial and venous mixed (AVOL map) regions (Fig. 1), similar to those described by LaViolette et al. [17].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows anatomical (T1w pre- and post-contrast images, T2w-FLAIR and ∆T1 maps), diffusion (ADC) and perfusion-derived (rCBV and AVOL) images for representative patients of each group (Breast (Fig. 2a), NSCLC (Fig. 2b) and ‘other’ (Fig. 2c), respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Qualitative analyses based on visual inspection revealed surrounding edema seen on T2w-FLAIR images, present on both patients in Fig. 2a and c and appeared in 83.9% of all lesions examined (respectively 85.1% for Breast, 86.0% for NSCLC and 80.9% for ‘other’ group).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ADC maps show higher values within tumor area (CET, red overlay), along with increased rCBV compared to NAWM (Fig. 2a, b and d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "AVOL maps are heterogeneous for both arterial and venous components while in clear cell kidney carcinoma case, tumor region is predominated by overlap mapQuantification of tumor volume, ADC and rCBV metrics within enhancing lesions\nQuantitatively, CET volumes in the non-breast, non-NSCLC ‘other’ group (median volume = 627.5 μl) were significantly larger than NSCLC (Fig. 3a; median volume = 236.0 μl, p = 0.0056) and primary breast cancer (median volume = 300.0 μl, p = 0.0003).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No significant difference in median CET ADC or median CET rCBV was observed between groups (Fig. 3b and C, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Median and interquartile ranges are reported\nBOLD rows in the table represent total characteristics for the entire patient cohort examined in the current study\nDifferences of AVOL components within enhancing lesions\nThe proportion of the CET with a statistically significant “arterial” ICA component (red, Fig. 4) was significantly larger in breast metastases (median = 27.33%) and NSCLC metastases (median = 32.57%) compared with the non-breast, non-NSCLC ‘other’ group (median = 15.12%, p = 0.0062 and p = 0.0018, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The percentage of overlap and its relationship with rCBV revealed highest linear correlation for breast: rCBV = 0.019*Arterial+ 1.551 (r = 0.68, p = 0.0002), NSCLC: rCBV = 0.013*Arterial+ 2.710 (r = 0.70, p < 0.0001) and ‘other’ group: rCBV = 0.021*Arterial+ 1.945 (r = 0.58, p < 0.0001) (Fig. 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "No significant linear correlation was observed when comparing rCBV to arterial (Fig. 5a) or venous components (Fig. 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows anatomical (T1w pre- and post-contrast images, T2w-FLAIR and ∆T1 maps), diffusion (ADC) and perfusion-derived (rCBV and AVOL) images for representative patients of each group (Breast (Fig. 2a), NSCLC (Fig. 2b) and ‘other’ (Fig. 2c), respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel b",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel c",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Qualitative analyses based on visual inspection revealed surrounding edema seen on T2w-FLAIR images, present on both patients in Fig. 2a and c and appeared in 83.9% of all lesions examined (respectively 85.1% for Breast, 86.0% for NSCLC and 80.9% for ‘other’ group).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The ADC maps show higher values within tumor area (CET, red overlay), along with increased rCBV compared to NAWM (Fig. 2a, b and d).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel a",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Quantification of tumor volume, ADC and rCBV metrics within enhancing lesions\nQuantitatively, CET volumes in the non-breast, non-NSCLC ‘other’ group (median volume = 627.5 μl) were significantly larger than NSCLC (Fig. 3a; median volume = 236.0 μl, p = 0.0056) and primary breast cancer (median volume = 300.0 μl, p = 0.0003).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No significant difference in median CET ADC or median CET rCBV was observed between groups (Fig. 3b and C, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Quantitatively, CET volumes in the non-breast, non-NSCLC ‘other’ group (median volume = 627.5 μl) were significantly larger than NSCLC (Fig. 3a; median volume = 236.0 μl, p = 0.0056) and primary breast cancer (median volume = 300.0 μl, p = 0.0003).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "No significant difference in median CET ADC or median CET rCBV was observed between groups (Fig. 3b and C, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel b",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Differences of AVOL components within enhancing lesions\nThe proportion of the CET with a statistically significant “arterial” ICA component (red, Fig. 4) was significantly larger in breast metastases (median = 27.33%) and NSCLC metastases (median = 32.57%) compared with the non-breast, non-NSCLC ‘other’ group (median = 15.12%, p = 0.0062 and p = 0.0018, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The proportion of the CET with a statistically significant “arterial” ICA component (red, Fig. 4) was significantly larger in breast metastases (median = 27.33%) and NSCLC metastases (median = 32.57%) compared with the non-breast, non-NSCLC ‘other’ group (median = 15.12%, p = 0.0062 and p = 0.0018, respectively).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The percentage of overlap and its relationship with rCBV revealed highest linear correlation for breast: rCBV = 0.019*Arterial+ 1.551 (r = 0.68, p = 0.0002), NSCLC: rCBV = 0.013*Arterial+ 2.710 (r = 0.70, p < 0.0001) and ‘other’ group: rCBV = 0.021*Arterial+ 1.945 (r = 0.58, p < 0.0001) (Fig. 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "No significant linear correlation was observed when comparing rCBV to arterial (Fig. 5a) or venous components (Fig. 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The percentage of overlap and its relationship with rCBV revealed highest linear correlation for breast: rCBV = 0.019*Arterial+ 1.551 (r = 0.68, p = 0.0002), NSCLC: rCBV = 0.013*Arterial+ 2.710 (r = 0.70, p < 0.0001) and ‘other’ group: rCBV = 0.021*Arterial+ 1.945 (r = 0.58, p < 0.0001) (Fig. 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "No significant linear correlation was observed when comparing rCBV to arterial (Fig. 5a) or venous components (Fig. 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  }
]